Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 14
Submit an article Journal homepage
215
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluation

Paliperidone: a new extended-release oral atypical antipsychotic

Heather Dlugosz Resident in Psychiatry, University of Cincinnati, Department of Psychiatry, College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0559, USA
, MD &
Henry A Nasrallah Professor of Psychiatry, Neurology and Neuroscience, University of Cincinnati, Department of Psychiatry, College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0559, USA +1 513 558 4615; +1 513 558 4516; [email protected]
, MD
Pages 2307-2313 | Published online: 10 Oct 2007

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Georgios Schoretsanitis, Edoardo Spina, Christoph Hiemke & Jose de Leon. (2018) A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone. Expert Review of Clinical Pharmacology 11:6, pages 625-639.
Read now
Pierre S Chue, Erin M MacKenzie, James A Chue & Glen B Baker. (2012) The pharmacology and formulation of paliperidone extended release. Expert Review of Neurotherapeutics 12:12, pages 1399-1410.
Read now
Pierre Chue & James Chue. (2012) A review of paliperidone palmitate. Expert Review of Neurotherapeutics 12:12, pages 1383-1397.
Read now
Stefania Ruiu, Maria Antonietta Casu, Gianluca Casu, Sara Piras & Giorgio Marchese. (2012) Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals. Expert Opinion on Pharmacotherapy 13:11, pages 1631-1643.
Read now
Maximilian Gahr, Markus A Kölle, Carlos Schönfeldt-Lecuona, Peter Lepping & Roland W Freudenmann. (2011) Paliperidone extended-release: does it have a place in antipsychotic therapy?. Drug Design, Development and Therapy 5, pages 125-146.
Read now

Articles from other publishers (14)

Khaled Greish, Aanchal Mathur, Moiz Bakhiet & Sebastien Taurin. (2018) Nanomedicine: is it lost in translation?. Therapeutic Delivery 9:4, pages 269-285.
Crossref
Robert Skibiński, Łukasz Komsta & Tadeusz Inglot. (2016) Characterization of paliperidone photodegradation products by LC-Q-TOF multistage mass spectrometry. Biomedical Chromatography 30:6, pages 894-901.
Crossref
Yawen Jiang & Weiyi Ni. (2015) Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment. Journal of Managed Care & Specialty Pharmacy 21:9, pages 780-792.
Crossref
Hongming Chen, Longshan Zhao, Guangjing Li, Donglei Leng, Panqin Ma, Lijin Tong & Tianhong Zhang. (2014) Development and validation of a rapid and sensitive UHPLC–MS/MS method for the determination of paliperidone in beagle dog plasma. Asian Journal of Pharmaceutical Sciences 9:5, pages 286-292.
Crossref
Yinbo Zhang & Guangzhi Dai. (2012) Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first‐episode schizophrenia through 52 weeks follow‐up in China. Human Psychopharmacology: Clinical and Experimental 27:6, pages 605-614.
Crossref
Pierre Baumann & Christoph Hiemke. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics 301 329 .
Michael Levine, Frank Lovecchio, Paul Tafoya & Robert Graham. (2011) Paliperidone Overdose With Delayed Onset of Toxicity. Annals of Emergency Medicine 58:1, pages 80-82.
Crossref
Edoardo Spina & Rosalia Crupi. (2011) Safety and Efficacy of Paliperidone Extended-Release in Acute and Maintenance Treatment of Schizophrenia. Journal of Central Nervous System Disease 3, pages JCNSD.S1607.
Crossref
Jose de Leon, Gary Wynn & Neil B. Sandson. (2010) The Pharmacokinetics of Paliperidone Versus Risperidone. Psychosomatics 51:1, pages 80-88.
Crossref
Min-Soo Lee & Hun Soo Chang. 2009. Schizophrenia. Schizophrenia 218 230 .
Joseph H. Porter & Adam J. Prus. (2008) Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies. Psychopharmacology 203:2, pages 279-294.
Crossref
Maria Geitona, Hara Kousoulakou, Markos Ollandezos, Kostas Athanasakis, Sotiria Papanicolaou & Ioannis Kyriopoulos. (2008) Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study. Annals of General Psychiatry 7:1.
Crossref
Andrew Cutler, Sara Ball & Stephen M. Stahl. (2014) Dosing Atypical Antipsychotics. CNS Spectrums 13:S9, pages 3-14.
Crossref
Abraham M Nussbaum & T S Stroup. (2008) Oral paliperidone for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.